Despite media narratives that often frame GLP-1 drugs as empowering, over half of women (52%) and more than a third of men (37%) believe users are judged negatively, seen as taking the easy way out
Non-arteritic anterior ischemic optic neuropathy (NAION) is a serious optic nerve disorder caused by reduced blood flow to the front portion of the optic nerve
Somatostatin, renowned for its potent inhibitory effects on both insulin and glucagon release, plays a pivotal role in the regulation of hormones
The Precision Peptide Genetic Test analyzes your genetic variants across thermoregulation, metabolic rate, and GLP-1 receptor sensitivity pathways
You want to seek out programs that offer direct contact with a medical provider for guidance, adjustments, and follow-up, explains Smith
and CT-868, a Phase II once-daily subcutaneous injectable, dual GLP-1/GIP receptor agonist intended for the treatment of type 1 diabetes patients who are overweight or with obesity